Donskov, F. .; Viggo Jensen, N. .; Smidt-Hansen, T. A Randomized Phase II Trial of Interleukin-2 and Interferon-α Plus Bevacizumab Versus Interleukin-2 and Interferon-α in Metastatic Renal-Cell Carcinoma (mRCC): Results from the Danish Renal Cancer Group (DaRenCa) Study-1. AO 2018, 57, 589-594.